Figure 3.
Subgroup analysis of ORR in NSCLC patients treated with camrelizumab. ORR, objective response rate; CI, confidence interval; NSCLC, non-small cell lung cancer; HBV, hepatitis B virus.
Subgroup analysis of ORR in NSCLC patients treated with camrelizumab. ORR, objective response rate; CI, confidence interval; NSCLC, non-small cell lung cancer; HBV, hepatitis B virus.